The Vascular Medicine Institute and Section of Benign Hematology are pleased to announce the addition of Yvette Yien, PhD, to our research community. Joining us from the University of Delaware, Dr. Yien will move her laboratory to the University of Pittsburgh School of Medicine starting August 1, 2021.
Dr. Yien’s research interests focus on erythropoiesis and iron metabolism. Dr. Yien received her Ph.D. in Biomedical Science (Developmental and Stem Cell Biology) at Mount Sinai School of Medicine, NY. As a postdoctoral fellow, she trained at the Brigham and Women’s Hospital, Harvard Medical School, in Dr. Barry Paw’s lab, where she characterized a genetic mutation in human CLPX, a novel regulatory gene in erythroid heme synthesis, that promotes erythropoietic protoporphyria. Since joining the University of Delaware as an Assistant Professor, her lab has elucidated a novel mechanism by which the mitochondrial inner membrane protein FAM210B coordinates the interplay between mitochondrial iron import and heme synthesis during terminal erythropoiesis. Dr. Yien is currently funded through a prestigious NIH R35 grant and a R03 grant. Dr. Yien will be joining the Vascular Medicine Institute and Section of Benign Hematology as an Associate Professor with tenure. Here, she intends to explore the mechanisms underlying the overarching regulation of heme synthesis by mitochondrial proteins.
Please join us in congratulating Dr. Yien on her new position at the University of Pittsburgh!
Stephen Chan and Enrico Novelli